Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis

Journal of Infectious Diseases

Volumn 203, Issue 7, 2011, Pages 1002-1011

  Suwannasaen, Duangchan ^a   Mahawantung, Jirawan ^a   Chaowagul, Wipada ^b   Limmathurotsakul, Direk ^c   Felgner, Philip L ^d   Davies, Huw ^d   Bancroft, Gregory J ^e   Titball, Richard W ^e   Lertmemongkolchai, Ganjana ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b Sappasitthiprasong Hospital   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CELL SURFACE PROTEIN; FLAGELLA HOOK ASSOCIATED PROTEIN; FLAGELLIN; GAMMA INTERFERON; INTERLEUKIN 12; LIPOPROTEIN; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN A; PEPTIDASE; PERIPLASMIC OLIGOPEPTIDE BINDING PROTEIN PRECURSOR; PROTEIN BIMA; PROTEIN BIPB; PROTEIN GROEL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE ALPHA; PUTATIVE HYDROPEROXIDE REDUCTASE; RIBOSOMAL PROTEIN S50; T LYMPHOCYTE RECEPTOR; TYPE IV PILUS PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BURKHOLDERIA PSEUDOMALLEI; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENVIRONMENTAL EXPOSURE; HEMAGGLUTINATION; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MELIOIDOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEIN PURIFICATION; RELAPSE;

ANTIBODIES, BACTERIAL; BURKHOLDERIA PSEUDOMALLEI; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MELIOIDOSIS; PROTEIN ARRAY ANALYSIS; T-LYMPHOCYTES;

EID: 79953019437     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq142     Document Type: Article

References (27)

1. Leelarasamee A. Recent development in melioidosis. Curr Opin Infect Dis 2004; 17:131-6. (Pubitemid 38453393)
2. Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 2000; 31:981-6. (Pubitemid 32299357)
3. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18:383-416. (Pubitemid 40548298)
4. Ngauy V, Lemeshev Y, Sadkowski L, Crawford G. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 2005; 43:970-2. (Pubitemid 40256075)
5. Limmathurotsakul D, Chaowagul W, Chierakul W, et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis 2006; 43:979-86. (Pubitemid 44631096)
6. Healey GD, Elvin SJ, Morton M, Williamson ED. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Infect Immun 2005; 73:5945-51.
7. Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun 1999; 67:3593-600. (Pubitemid 29291534)
8. Haque A, Easton A, Smith D, et al. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis 2006; 193:370-9. (Pubitemid 43122336)
9. + T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol 2001; 166:1097-105.
10. Tippayawat P, Saenwongsa W, Mahawantung J, et al. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei. PLoS Negl Trop Dis 2009; 3:e407.
11. Sundaresh S, Randall A, Unal B, et al. From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics 2007; 23:i508-18.
12. Xu Y, Bruno JF, Luft BJ. Profiling the humoral immune response to Borrelia burgdorferi infection with protein microarrays. Microb Pathog 2008; 45:403-7. (Pubitemid 50336682)
13. Doolan DL, Mu Y, Unal B, et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008; 8:4680-94.
14. Jing L, Davies DH, Chong TM, et al. An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling. J Virol 2008; 82:7120-34. (Pubitemid 351977730)
15. Benhnia MR, McCausland MM, Su HP, et al. Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine. J Virol 2008; 82:3751-68. (Pubitemid 351429950)
16. Davies DH, Wyatt LS, Newman FK, et al. Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J Virol 2008; 82:652-63.
17. Felgner PL, Kayala MA, Vigil A, et al. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A 2009; 106:13499-504.
18. Davies DH, McCausland MM, Valdez C, et al. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol 2005; 79:11724-33. (Pubitemid 41279291)
19. Alexander AD, Huxsoll DL, Warner AR Jr, Shepler V, Dorsey A. Serological diagnosis of human melioidosis with indirect hemagglutination and complement fixation tests. Appl Microbiol 1970; 20:825-33.
20. Davies DH, Liang X, Hernandez JE, et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci USA 2005; 102:547-52. (Pubitemid 40282702)
21. Eyles JE, Unal B, Hartley MG, et al. Immunodominant Francisella tularensis antigens identified using proteome microarray. Proteomics 2007; 7:2172-83.
22. Bacarese-Hamilton T, Bistoni F, Crisanti A. Protein microarrays: from serodiagnosis to whole proteome scale analysis of the immune response against pathogenic microorganisms. Biotechniques 2002: 24-9. (Pubitemid 36008160)
23. Hara Y, Mohamed R, Nathan S. Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets. PLoS One 2009; 4:e6496.
24. Harland DN, Chu K, Haque A, et al. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Infect Immun 2007; 75:4173-80. (Pubitemid 47206316)
25. Luo D, Ni B, Li P, et al. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice. Infect Immun 2006; 74:2734-41. (Pubitemid 43672982)
26. Olsen I, Reitan LJ, Holstad G, Wiker HG. Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium avium subsp. paratuberculosis. Infect Immun 2000; 68:801-8. (Pubitemid 30056539)
27. Holden MT, Titball RW, Peacock SJ, et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci USA 2004; 101:14240-5. (Pubitemid 39305059)